Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Piya Chaemsaithong, María M. Gil, Noppadol Chaiyasit, Diana Cuenca-Gomez, Walter Plasencia, Valeria Rolle & Liona C. Poon. (2023) Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 229:3, pages 222-247.
Crossref
Hyo Ju Yang, Soo Yeon Lim, Hyun Soo Kim, Chang Won Choi & Young Hwa Jung. (2023) Associations between Maternal sFlt-1/PlGF Ratio and Perinatal and Neonatal Outcomes in Newborns Born to Mothers with Preeclampsia. Neonatal Medicine 30:3, pages 61-68.
Crossref
Magda Rybak-Krzyszkowska, Jakub Staniczek, Adrianna Kondracka, Joanna Bogusławska, Sebastian Kwiatkowski, Tomasz Góra, Michał Strus & Wojciech Górczewski. (2023) From Biomarkers to the Molecular Mechanism of Preeclampsia—A Comprehensive Literature Review. International Journal of Molecular Sciences 24:17, pages 13252.
Crossref
Alexandros Velegrakis, Elisavet Kouvidi, Persefoni Fragkiadaki & Stavros Sifakis. (2023) Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: An update (Review). International Journal of Molecular Medicine 52:4.
Crossref
Kamil Grubczak, Aleksandra Starosz, Barbara Makowska, Zuzanna Parfienowicz, Magdalena Krętowska, Beata Naumnik & Marcin Moniuszko. (2023) The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model. Scientific Reports 13:1.
Crossref
Ashley N. Battarbee, Lisa Mele, Mark B. Landon, Michael W. Varner, Brian M. Casey, Uma M. Reddy, Ronald J. Wapner, Dwight J. Rouse, John M. Thorp, Edward K. Chien, George Saade, Alan M. Peaceman & Sean C. Blackwell. (2023) Hypertensive Disorders of Pregnancy and Long-Term Maternal Cardiovascular and Metabolic Biomarkers. American Journal of Perinatology.
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Dustyn Levenson & Adi L. Tarca. (2023) One-third of patients with eclampsia at term do not have an abnormal angiogenic profile. Journal of Perinatal Medicine 51:5, pages 652-663.
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Katarzyna Pankiewicz & Tadeusz Issat. (2023) Understanding the Role of Chemerin in the Pathophysiology of Pre-Eclampsia. Antioxidants 12:4, pages 830.
Crossref
Weronika Dymara-Konopka, Marzena Laskowska, Ewelina Grywalska, Anna Hymos, Anna Błażewicz & Bożena Leszczyńska-Gorzelak. (2023) Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences 24:2, pages 972.
Crossref
Sultan Şalk, Nazan Yurtcu & Ali Çetin. (2022) Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study. Journal of Turkish Society of Obstetric and Gynecology 19:4, pages 268-274.
Crossref
Ayfer Ozer Cora, Suleyman Guven, Hidayet Sal, Ilknur Tosun & Emine Seda Guvendag Guven. (2022) Serum MUC3 Protein as a Novel Marker of Gestational Hypertensive Disorders. The Journal of Obstetrics and Gynecology of India 72:6, pages 497-502.
Crossref
Yang Liu, Xingli Gao, Songwei Gao, Yu Song, Yongran Guo & Jing Cao. (2022) Placental Therapeutic Targets and Nanodelivery Systems. Molecular Pharmaceutics 19:11, pages 3730-3748.
Crossref
Adi L. Tarca, Roberto Romero, Gaurav Bhatti, Francesca Gotsch, Bogdan Done, Dereje W. Gudicha, Dahiana M. Gallo, Eunjung Jung, Roger Pique-Regi, Stanley M. Berry, Tinnakorn Chaiworapongsa & Nardhy Gomez-Lopez. (2022) Human Plasma Proteome During Normal Pregnancy. Journal of Proteome Research 21:11, pages 2687-2702.
Crossref
Roberto Romero, Eunjung Jung, Tinnakorn Chaiworapongsa, Offer Erez, Dereje W. Gudicha, Yeon Mee Kim, Jung-Sun Kim, Bomi Kim, Juan Pedro Kusanovic, Francesca Gotsch, Andreea B. Taran, Bo Hyun Yoon, Sonia S. Hassan, Chaur-Dong Hsu, Piya Chaemsaithong, Nardhy Gomez-Lopez, Lami Yeo, Chong Jai Kim & Adi L. Tarca. (2022) Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. American Journal of Obstetrics and Gynecology 227:4, pages 615.e1-615.e25.
Crossref
Alice Hurrell, Jenie Sparkes, Kate Duhig, Paul T. Seed, Jenny Myers, Cheryl Battersby, Katherine Clark, Marcus Green, Rachael M. Hunter, Andrew H. Shennan, Lucy C. Chappell & Louise Webster. (2022) Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2). Trials 23:1.
Crossref
Daniela Moraes, Camila Milioni, Carolina Friske Vieira, Eveline Avila Parera, Bárbara Dewes Silva, Miriam Viviane Baron, Bartira Ercília Pinheiro da Costa & Carlos Eduardo Poli-de-Figueiredo. (2022) Immature Platelet Fraction and Thrombin Generation: Preeclampsia Biomarkers. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 44:08, pages 771-775.
Crossref
Thanaphan Thitivichienlert, Chadakarn Phaloprakarn & Thananda Trakarnvanich. (2022) Long-term observational study of renal outcome after preeclampsia: Role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin. Annals of Medicine and Surgery 78, pages 103818.
Crossref
Graham W Aberdeen, Jeffery S Babischkin, Jonathan R Lindner, Gerald J Pepe & Eugene D Albrecht. (2022) Placental sFlt-1 Gene Delivery in Early Primate Pregnancy Suppresses Uterine Spiral Artery Remodeling. Endocrinology 163:4.
Crossref
Marlene Shaw-Gallagher, Flor A. Rangel, Kelly A. Sweeney, Jyothi Digambaranath, Faraaz Siddiqui, Megan McKay, Kimberly Gadulka & Jane S. Davis. (2022) Everything Else. Physician Assistant Clinics 7:2, pages 305-317.
Crossref
Anne Dathan-Stumpf, Anna Rieger, Stefan Verlohren, Cyrill Wolf & Holger Stepan. (2022) sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation. PLOS ONE 17:2, pages e0263443.
Crossref
Pablo Torres-Vergara, Robin Rivera & Carlos Escudero. (2022) How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?. Frontiers in Physiology 12.
Crossref
Ruqaiya Shahid, Muhammad F. Bari & Mehwish Hussain. (2022) Serum biomarkers for the prediction and diagnosis of preeclampsia: A meta-analysis. Journal of Taibah University Medical Sciences 17:1, pages 14-27.
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Michal Fishel Bartal, Marshall D. Lindheimer & Baha M. Sibai. (2022) Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. American Journal of Obstetrics and Gynecology 226:2, pages S819-S834.
Crossref
Adi L. Tarca, Andreea Taran, Roberto Romero, Eunjung Jung, Carmen Paredes, Gaurav Bhatti, Corina Ghita, Tinnakorn Chaiworapongsa, Nandor Gabor Than & Chaur-Dong Hsu. (2022) Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. American Journal of Obstetrics and Gynecology 226:1, pages 126.e1-126.e22.
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
165
185
.
Usman M. AshrafDalton L. HallAdam Z. RawlsBarbara T. Alexander. (2021) Epigenetic processes during preeclampsia and effects on fetal development and chronic health. Clinical Science 135:19, pages 2307-2327.
Crossref
Thajasvarie Naicker, Nalini Govender, Tashlen Abel, Nitalia Naidoo, Merantha Moodley, Yazira Pillay, Shoohana Singh, Olive Pearl Khaliq & Jagidesa Moodley. (2021) HIV Associated Preeclampsia: A Multifactorial Appraisal. International Journal of Molecular Sciences 22:17, pages 9157.
Crossref
Eugene D. Albrecht, Jeffery S. BabischkinGraham W. AberdeenMarcia G. Burch & Gerald J. Pepe. (2021) Maternal systemic vascular dysfunction in a primate model of defective uterine spiral artery remodeling. American Journal of Physiology-Heart and Circulatory Physiology 320:4, pages H1712-H1723.
Crossref
Nitalia Naidoo, Jagidesa Moodley & Thajasvarie Naicker. (2021) Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review. Hypertension Research 44:4, pages 386-398.
Crossref
Revathi Soundararajan, Sunitha C. Suresh, Ariel Mueller, Sarah Heimberger, Smitha Avula, Chaitra Sathyanarayana, Sunitha Mahesh, Sushma Madhuprakash & Sarosh Rana. (2021) Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study. Pregnancy Hypertension 23, pages 97-103.
Crossref
A Hurrell, A Beardmore‐Gray, K Duhig, L Webster, LC Chappell & AH Shennan. (2020) Placental growth factor in suspected preterm pre‐eclampsia: a review of the evidence and practicalities of implementation. BJOG: An International Journal of Obstetrics & Gynaecology 127:13, pages 1590-1597.
Crossref
Eugene D. Albrecht & Gerald J. Pepe. (2020) Regulation of Uterine Spiral Artery Remodeling: a Review. Reproductive Sciences 27:10, pages 1932-1942.
Crossref
Xueli Dai, Yufen Fu & Yuanhua Ye. (2020) Increased NDRG1 expression suppresses angiogenesis via PI3K/AKT pathway in human placental cells. Pregnancy Hypertension 21, pages 106-110.
Crossref
Akihiro Kawashima, Tomohiro Oba, Rika Yasuhara, Bunbu Sekiya & Akihiko Sekizawa. (2020) Cytokine profiles in maternal serum are candidates for predicting an optimal timing for the delivery in early‐onset fetal growth restriction. Prenatal Diagnosis 40:6, pages 728-737.
Crossref
Makmur Sitepu & Jusuf Rachmadsyah. 2019. Prediction of Maternal and Fetal Syndrome of Preeclampsia. Prediction of Maternal and Fetal Syndrome of Preeclampsia.
Xinhua Chen, Xuxia Xi, Fan Cui, Ming Wen, Aijuan Hong, Zemei Hu & Juan Ni. (2019) Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia. Journal of International Medical Research 47:10, pages 4673-4682.
Crossref
Carin Black, Ahmed Al-Amin, Daniel Lorber Rolnik, Stefan C. Kane, Caroline Stolarek, Adrienne White, Fabricio da Silva Costa & Shaun Brennecke. (2019) Midpregnancy testing for soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF): An inter-assay comparison of three automated immunoassay platforms. Placenta 86, pages 11-14.
Crossref
Sankat Mochan, Manoj Kumar Dhingra, Sunil Kumar Gupta, Shobhit Saxena, Pallavi Arora, Vineeta Yadav, Neerja Rani, Kalpana Luthra, Sadanand Dwivedi, Neerja Bhatla & Renu Dhingra. (2019) Status of VEGF in preeclampsia and its effect on endoplasmic reticulum stress in placental trophoblast cells. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 4, pages 100070.
Crossref
Sayuri Padayachee, Jagidesa Moodley & Thajasvarie Naicker. (2019) A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy. Current Hypertension Reports 21:9.
Crossref
Caroline Ruth Mathias & Carmela Rizvi. (2019) The diagnostic conundrum of maternal mirror syndrome progressing to pre-eclampsia – A case report. Case Reports in Women's Health 23, pages e00122.
Crossref
Weronika Dymara-Konopka & Marzena Laskowska. (2019) The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review. International Journal of Molecular Sciences 20:11, pages 2757.
Crossref
Adi L. Tarca, Roberto Romero, Neta Benshalom-Tirosh, Nandor Gabor Than, Dereje W. Gudicha, Bogdan Done, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Panaitescu, Dan Tirosh, Nardhy Gomez-Lopez, Sorin Draghici, Sonia S. Hassan & Offer Erez. (2019) The prediction of early preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 14:6, pages e0217273.
Crossref
Yosef Laviv, Joshua L. Wang, Matthew P. Anderson & Ekkehard M. Kasper. (2017) Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway. Neurosurgical Review 42:2, pages 209-226.
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Megan A. SheridanYing YangAshish Jain, Alex S. LyonsPenghua YangSambasiva R. BrahmasaniAihua DaiYuchen TianMark R. EllersieckGeetu TutejaDanny J. Schust, Laura C. Schulz, Toshihiko EzashiR. Michael Roberts. (2019) Early onset preeclampsia in a model for human placental trophoblast. Proceedings of the National Academy of Sciences 116:10, pages 4336-4345.
Crossref
Lucia Procopciuc, G. Nemeti, I. Goidescu, E. Buzdugan & Gabriela C. Zaharie. (2019) Angiogenic factors in normal pregnancy and preeclampsia. Obstetrica şi Ginecologia 2:67, pages 61.
Crossref
Ryosuke Kikuchi, Megan Stevens, Kazuhiro Harada, Sebastian Oltean & Toyoaki Murohara. 2019.
1
33
.
Gabriele Tonni, Edward Araujo Júnior & Maria Paola Bonasoni. 2019. Fetal Growth Restriction. Fetal Growth Restriction
41
64
.
Ylbe Palacios de Franco, Karina Velazquez, Natalia Segovia, Gladys Sandoval, Estefania Gauto, Ylbe V. Franco Palacios & Carlos R Franco Palacios. (2018) Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia. Brazilian Journal of Nephrology 40:4, pages 339-343.
Crossref
Ritu Mogra. (2018) Screening and prevention of pre‐term pre‐eclampsia – A prime time to act. Australasian Journal of Ultrasound in Medicine 21:4, pages 187-190.
Crossref
Ruby Minhas, Danielle Young, Rabab Naseem, Ariel Mueller, Sireesha Chinthala, Joana Lopes Perdigao, Kiang-Teck J. Yeo, Siaw Li Chan, Avery Tung, Julia Bregand White, Sajid Shahul & Sarosh Rana. (2018) Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertension 14, pages 110-114.
Crossref
Undurti N Das. (2018) Circulating MicroRNAs and Bioactive Lipids in Pre-Eclampsia and Its Cardiovascular Sequelae. American Journal of Hypertension 31:10, pages 1079-1086.
Crossref
Karla Neves, Augusto Montezano, Rheure Alves-Lopes, Thiago Bruder-Nascimento, Rafael Costa, Roberto Costa, Rhian Touyz & Rita Tostes. (2018) Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice. International Journal of Molecular Sciences 19:8, pages 2454.
Crossref
Nandor Gabor Than, Roberto Romero, Adi Laurentiu Tarca, Katalin Adrienna Kekesi, Yi Xu, Zhonghui Xu, Kata Juhasz, Gaurav Bhatti, Ron Joshua Leavitt, Zsolt Gelencser, Janos Palhalmi, Tzu Hung Chung, Balazs Andras Gyorffy, Laszlo Orosz, Amanda Demeter, Anett Szecsi, Eva Hunyadi-Gulyas, Zsuzsanna Darula, Attila Simor, Katalin Eder, Szilvia Szabo, Vanessa Topping, Haidy El-Azzamy, Christopher LaJeunesse, Andrea Balogh, Gabor Szalai, Susan Land, Olga Torok, Zhong Dong, Ilona Kovalszky, Andras Falus, Hamutal Meiri, Sorin Draghici, Sonia S. Hassan, Tinnakorn Chaiworapongsa, Manuel Krispin, Martin Knöfler, Offer Erez, Graham J. Burton, Chong Jai Kim, Gabor Juhasz & Zoltan Papp. (2018) Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia. Frontiers in Immunology 9.
Crossref
Janri Geldenhuys, Theresa Marie Rossouw, Hendrik Andries Lombaard, Marthie Magdaleen Ehlers & Marleen Magdalena Kock. (2018) Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia. Frontiers in Immunology 9.
Crossref
Erin CiampaYunping LiSimon Dillon, Edouard LecarpentierLaura SorabellaTowia A. Libermann, S. Ananth KarumanchiPhilip E. Hess. (2018) Cerebrospinal Fluid Protein Changes in Preeclampsia. Hypertension 72:1, pages 219-226.
Crossref
Sarosh Rana, Saira Salahuddin, Ariel Mueller, Anders H. Berg, Ravi I. Thadhani & S. Ananth Karumanchi. (2018) Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertension 13, pages 100-106.
Crossref
Maria Portelli & Byron Baron. (2018) Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns. Journal of Pregnancy 2018, pages 1-23.
Crossref
Suzanne D. Burke & S. Ananth Karumanchi. 2018. Preeclampsia. Preeclampsia
227
237
.
Holger Stepan & Janine Hoffmann. 2018. Preeclampsia. Preeclampsia
175
198
.
Tinnakorn Chaiworapongsa, Roberto Romero, Offer Erez, Adi L. Tarca, Agustin Conde-Agudelo, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan, Lami Yeo & Steven J. Korzeniewski. (2017) The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). American Journal of Obstetrics and Gynecology 217:6, pages 682.e1-682.e13.
Crossref
Gustavo Adolfo Ospina-Tascón, Albaro José Nieto Calvache, Edgardo Quiñones, Humberto José Madriñan, Juan David Valencia, William Fernando Bermúdez, Javier Carvajal, María Fernanda Escobar & Daniel de Backer. (2017) Microcirculatory blood flow derangements during severe preeclampsia and HELLP syndrome. Pregnancy Hypertension 10, pages 124-130.
Crossref
Anshul Jadli, Kanjaksha Ghosh, Purnima Satoskar, Kaizad Damania, Vandana Bansal & Shrimati Shetty. (2017) Combination of copeptin, placental growth factor and total annexin V microparticles for prediction of preeclampsia at 10–14 weeks of gestation. Placenta 58, pages 67-73.
Crossref
Undurti N Das. (2017) Angiogenic, Antiangiogenic Molecules, and Bioactive Lipids in Preeclampsia. American Journal of Hypertension 30:9, pages 864-870.
Crossref
Roberto Romero, Offer Erez, Maik Hüttemann, Eli Maymon, Bogdan Panaitescu, Agustin Conde-Agudelo, Percy Pacora, Bo Hyun Yoon & Lawrence I. Grossman. (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology 217:3, pages 282-302.
Crossref
Alexandros Velegrakis, Maria Sfakiotaki & Stavros Sifakis. (2017) Human placental growth hormone in normal and abnormal fetal growth. Biomedical Reports 7:2, pages 115-122.
Crossref
Offer Erez, Roberto Romero, Eli Maymon, Piya Chaemsaithong, Bogdan Done, Percy Pacora, Bogdan Panaitescu, Tinnakorn Chaiworapongsa, Sonia S. Hassan & Adi L. Tarca. (2017) The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 12:7, pages e0181468.
Crossref
Heather Allison BoydSaima BasitIda BehrensElisabeth LeirgulHenning BundgaardJan WohlfahrtMads MelbyeNina Øyen. (2017) Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies. Circulation 136:1, pages 39-48.
Crossref
Belinda Jim & S. Ananth Karumanchi. (2017) Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. Seminars in Nephrology 37:4, pages 386-397.
Crossref
Roberto Romero, Offer Erez, Eli Maymon, Piya Chaemsaithong, Zhonghui Xu, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Done, Sonia S. Hassan & Adi L. Tarca. (2017) The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. American Journal of Obstetrics and Gynecology 217:1, pages 67.e1-67.e21.
Crossref
Kathryn J. LindleyShayna N. ConnerAlison G. CahillEric NovakDouglas L. Mann. (2017) Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum Cardiomyopathy. Circulation: Heart Failure 10:6.
Crossref
Takuji Tomimatsu, Kazuya Mimura, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2016) Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertension Research 40:4, pages 305-310.
Crossref
Carlos A. Labarrere, Hector L. DiCarlo, Elaine Bammerlin, James W. Hardin, Yeon M. Kim, Piya Chaemsaithong, David M. Haas, Ghassan S. Kassab & Roberto Romero. (2017) Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. American Journal of Obstetrics and Gynecology 216:3, pages 287.e1-287.e16.
Crossref
Sarosh Rana & S. Ananth Karumanchi. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
1724
1732.e2
.
S.A. Karumanchi. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease
555
594
.
Susanne Schrey-Petersen & Holger Stepan. (2017) Anti-angiogenesis and Preeclampsia in 2016. Current Hypertension Reports 19:1.
Crossref
Anita Virtanen, Tarja Toimela, Kati Tihtonen, Jertta-Riina Sarkanen, Outi Huttala, Tuula Heinonen & Jukka Uotila. (2016) Strong inhibitory effect of pre-eclampsia serum on angiogenesis detected in vitro by human cell-based angiogenesis tests. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 6:4, pages 367-373.
Crossref
Neil A. Nadkarni, Augustine Rajakumar, Nikita Mokhashi, Suzanne D. Burke, Sarosh Rana, Saira Salahuddin, Quynh Dang, Ravi Thadhani, Ramaswamy Krishnan, Thomas P. Stossel & S. Ananth Karumanchi. (2016) Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 6:4, pages 333-339.
Crossref
Zsuzsanna K. Zsengellér, Augustine Rajakumar, Jon T. Hunter, Saira Salahuddin, Sarosh Rana, Isaac E. Stillman & S. Ananth Karumanchi. (2016) Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 6:4, pages 313-319.
Crossref
Juan Yang, Michelle Pearl, Gerald N. DeLorenze, Roberto Romero, Zhong Dong, Laura Jelliffe-Pawlowski, Robert Currier, Monica Flessel & Martin Kharrazi. (2016) Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors. American Journal of Obstetrics and Gynecology 215:3, pages 359.e1-359.e9.
Crossref
Suzanne D. Burke, Zsuzsanna K. Zsengellér, Eliyahu V. Khankin, Agnes S. Lo, Augustine Rajakumar, Jennifer J. DuPont, Amy McCurley, Mary E. Moss, Dongsheng Zhang, Christopher D. Clark, Alice Wang, Ellen W. Seely, Peter M. Kang, Isaac E. Stillman, Iris Z. Jaffe & S. Ananth Karumanchi. (2016) Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. Journal of Clinical Investigation 126:7, pages 2561-2574.
Crossref
S. Ananth Karumanchi. (2016) Angiogenic Factors in Preeclampsia. Hypertension 67:6, pages 1072-1079.
Crossref
Steven J. Korzeniewski, Roberto Romero, Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan & Lami Yeo. (2016) Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. American Journal of Obstetrics and Gynecology 214:5, pages 629.e1-629.e17.
Crossref
Swati Anand, SydneyA. Young, M. Sean Esplin, Benjamin Peaden, H. Dennis Tolley, T. Flint Porter, Michael W. Varner, Mary E. D'Alton, Bruce J. Jackson & Steven W. Graves. (2016) Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry. Journal of Lipid Research 57:4, pages 687-696.
Crossref
Christina S. BartlettMarie JeanssonSusan E. Quaggin. (2016) Vascular Growth Factors and Glomerular Disease. Annual Review of Physiology 78:1, pages 437-461.
Crossref
Harapan Harapan & Cut Meurah Yeni. (2015) The role of microRNAs on angiogenesis and vascular pressure in preeclampsia: The evidence from systematic review. Egyptian Journal of Medical Human Genetics 16:4, pages 313-325.
Crossref
Szilvia Szabo, Meera Mody, Roberto Romero, Yi Xu, Katalin Karaszi, Noemi Mihalik, Zhonghui Xu, Gaurav Bhatti, Tibor Fule, Petronella Hupuczi, Tibor Krenacs, Janos RigoJr.Jr., Adi L. Tarca, Sonia S. Hassan, Tinnakorn Chaiworapongsa, Ilona Kovalszky, Zoltan Papp & Nandor Gabor Than. (2015) Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome. Pathology & Oncology Research 21:3, pages 659-668.
Crossref
Swati Anand, Tanielle Mei Bench Alvarez, W Evan Johnson, M Sean Esplin, Karen Merrell, T Flint Porter & Steven W Graves. (2015) Serum biomarkers predictive of pre-eclampsia. Biomarkers in Medicine 9:6, pages 563-575.
Crossref
Aggeliki Kolialexi, Danai Mavreli, Georgia Tounta, Ariadni Mavrou & Nikolas Papantoniou. (2015) Urine proteomic studies in preeclampsia. PROTEOMICS – Clinical Applications 9:5-6, pages 501-506.
Crossref
Gabor Szalai, Roberto Romero, Tinnakorn Chaiworapongsa, Yi Xu, Bing Wang, Hyunyoung Ahn, Zhonghui Xu, Po Jen Chiang, Birgitta Sundell, Rona Wang, Yang Jiang, Olesya Plazyo, Mary Olive, Adi L. Tarca, Zhong Dong, Faisal Qureshi, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2015) Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice. PLOS ONE 10:4, pages e0119547.
Crossref
Valeria C. Sandrim, Ana C. T. Palei, Nibia Eleuterio, Jose E. Tanus-Santos & Ricardo C. Cavalli. (2014) Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms. Archives of Gynecology and Obstetrics 291:4, pages 799-803.
Crossref
H. Stepan, I. Herraiz, D. Schlembach, S. Verlohren, S. Brennecke, F. Chantraine, E. Klein, O. Lapaire, E. Llurba, A. Ramoni, M. Vatish, D. Wertaschnigg & A. Galindo. (2015)
Implementation of the
sFlt
‐1/
PlGF
ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
. Ultrasound in Obstetrics & Gynecology 45:3, pages 241-246.
Crossref
Y Giguère, J Massé, S Thériault, E Bujold, J Lafond, F Rousseau & J-C Forest. (2015) Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. BJOG: An International Journal of Obstetrics & Gynaecology 122:3, pages 402-410.
Crossref
Elisa Llurba, Fatima Crispi & Stefan Verlohren. (2015) Update on the Pathophysiological Implications and Clinical Role of Angiogenic Factors in Pregnancy. Fetal Diagnosis and Therapy 37:2, pages 81-92.
Crossref
Agustin Conde-Agudelo, Roberto Romero & James M. Roberts. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
221
251
.
Gabor Szalai, Yi Xu, Roberto Romero, Tinnakorn Chaiworapongsa, Zhonghui Xu, Po Jen Chiang, Hyunyoung Ahn, Birgitta Sundell, Olesya Plazyo, Yang Jiang, Mary Olive, Bing Wang, Suzanne M. Jacques, Faisal Qureshi, Adi L. Tarca, Offer Erez, Zhong Dong, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2014) In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy. PLoS ONE 9:11, pages e110867.
Crossref
N.G. Than, R. Romero, Y. Xu, O. Erez, Z. Xu, G. Bhatti, R. Leavitt, T.H. Chung, H. El-Azzamy, C. LaJeunesse, B. Wang, A. Balogh, G. Szalai, S. Land, Z. Dong, S.S. Hassan, T. Chaiworapongsa, M. Krispin, C.J. Kim, A.L. Tarca, Z. Papp & H. Bohn. (2014) Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta 35:11, pages 855-865.
Crossref
Rebecca E. Allen, Ewelina Rogozinska, Kirsty Cleverly, Joseph Aquilina & S. Thangaratinam. (2014) Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 182, pages 194-201.
Crossref
Anjali Acharya, Wunnie Brima, Shivakanth Burugu & Tanvi Rege. (2014) Prediction of Preeclampsia-Bench to Bedside. Current Hypertension Reports 16:11.
Crossref
María G. Cardenas-Mondragon, Gabriela Vallejo-Flores, Jose Delgado-Dominguez, Juan F. Romero-Arauz, Alejandro Gomez-Delgado, Guadalupe Aguilar-Madrid, Juan J. Sanchez-Barriga & Janeth Marquez-Acosta. (2014) Preeclampsia Is Associated with Lower Production of Vascular Endothelial Growth Factor by Peripheral Blood Mononuclear Cells. Archives of Medical Research 45:7, pages 561-569.
Crossref
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Steven J. Korzeniewski, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 2: prediction, prevention and management. Nature Reviews Nephrology 10:9, pages 531-540.
Crossref
Nándor Gábor Than, Andrea Balogh, Roberto Romero, Éva Kárpáti, Offer Erez, András Szilágyi, Ilona Kovalszky, Marei Sammar, Sveinbjorn Gizurarson, János Matkó, Péter Závodszky, Zoltán Papp & Hamutal Meiri. (2014) Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy. Frontiers in Immunology 5.
Crossref
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 1: current understanding of its pathophysiology. Nature Reviews Nephrology 10:8, pages 466-480.
Crossref
Akriti S Sahay, Vidya V Patil, Deepali P Sundrani, Asmita A Joshi, Girija N Wagh, Sanjay A Gupte & Sadhana R Joshi. (2014) A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertension Research 37:8, pages 753-758.
Crossref
Lalita Kulmala & Vorapong Phupong. (2014) Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida. Hypertension Research 37:6, pages 538-542.
Crossref
Tereza Cindrova-Davies. (2014) The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia. Frontiers in Pharmacology 5.
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
JIMMY ESPINOZA. (2014) ANGIOGENIC IMBALANCES IN THE PATHOGENESIS OF PREGNANCY COMPLICATIONS. Fetal and Maternal Medicine Review 25:1, pages 42-58.
Crossref
William Mifsud & Neil J. Sebire. (2014) Placental Pathology in Early-Onset and Late-Onset Fetal Growth Restriction. Fetal Diagnosis and Therapy 36:2, pages 117-128.
Crossref
K.W. Yi, S.H. Jung, G.J. Cho, H.J. Seol, S.C. Hong, M.J. Oh & H.J. Kim. (2014) Effects of sFlt-1 and alpha 2-macroglobulin on vascular endothelial growth factor-induced endothelin-1 upregulation in human microvascular endothelial cells. Placenta 35:1, pages 64-69.
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref
Lei Ji, Jelena Brkić, Ming Liu, Guodong Fu, Chun Peng & Yan-Ling Wang. (2013) Placental trophoblast cell differentiation: Physiological regulation and pathological relevance to preeclampsia. Molecular Aspects of Medicine 34:5, pages 981-1023.
Crossref
Salah Aref, Hosam Goda & Ebrahim Abdelaal. (2013) Circulating Vascular Growth Factor (VEGF) Angiopoietin-1 (Angi-1) and Soluble Tie-2 Receptor in Pregnancy Complicated with Pre-eclampsia: A Prospective Study. The Journal of Obstetrics and Gynecology of India 63:5, pages 316-320.
Crossref
Sun Min Kim, Joong Shin Park, Errol R. Norwitz, Hee Jung Jung, Byoung Jae Kim, Chan-Wook Park & Jong Kwan Jun. (2013) Circulating Levels of Neutrophil Gelatinase–Associated Lipocalin (NGAL) Correlate With the Presence and Severity of Preeclampsia. Reproductive Sciences 20:9, pages 1083-1089.
Crossref
WT Schnettler, D Dukhovny, J Wenger, S Salahuddin, SJ Ralston & S Rana. (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1224-1232.
Crossref
Szilvia Szabo, Yi Xu, Roberto Romero, Tibor Fule, Katalin Karaszi, Gaurav Bhatti, Tibor Varkonyi, Ildiko Varkonyi, Tibor Krenacs, Zhong Dong, Adi L. Tarca, Tinnakorn Chaiworapongsa, Sonia S. Hassan, Zoltan Papp, Ilona Kovalszky & Nandor Gabor Than. (2013) Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Archiv 463:3, pages 445-458.
Crossref
Leandro De Oliveira, José C. Peraçoli, Maria T. Peraçoli, Henri Korkes, Giafranco Zampieri, Antonio F. Moron & Nelson Sass. (2013) sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 3:3, pages 191-195.
Crossref
Mihran V. Naljayan & S. Ananth Karumanchi. (2013) New Developments in the Pathogenesis of Preeclampsia. Advances in Chronic Kidney Disease 20:3, pages 265-270.
Crossref
Amy E. Whitten, Roberto Romero, Steven J. Korzeniewski, Adi L. Tarca, Alyse G. Schwartz, Lami Yeo, Zhong Dong, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2013) Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. American Journal of Obstetrics and Gynecology 208:4, pages 310.e1-310.e11.
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Juan Pedro Kusanovic, Eleazar Soto, Jennifer Lam, Zhong Dong, Nandor G. Than, Lami Yeo, Edgar Hernandez-Andrade, Agustín Conde-Agudelo & Sonia S. Hassan. (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. American Journal of Obstetrics and Gynecology 208:4, pages 287.e1-287.e15.
Crossref
Jamie A. Bastek & Michal A. Elovitz. (2013) The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia. Fertility and Sterility 99:4, pages 1117-1123.
Crossref
R Tripathi, R Ralhan, S Saxena, S Salhan & G Rath. (2012) Soluble VEGFR-1 in pathophysiology of pregnancies complicated by hypertensive disorders: the Indian scenario. Journal of Human Hypertension 27:2, pages 107-114.
Crossref
Mahmoud Fathy Hassan, Nancy Mohamed Ali Rund & Ahmed Husseiny Salama. (2013) An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia. Obstetrics and Gynecology International 2013, pages 1-8.
Crossref
V.L. Karanam, N. Anim-Nyame & N.M. Page. (2013) Placental angiogenin inhibitor (ribonuclease inhibitor), a novel gene in pre-eclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 3:1, pages 39-43.
Crossref
Catherine L. Haggerty, Inge Panum, Soren A. Uldum, Debra C. Bass, Jorn Olsen, Toni Darville, Jamie M. Eastman, Hyagriv N. Simhan, James M. Roberts & Roberta B. Ness. (2013) Chlamydia trachomatis infection may increase the risk of preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 3:1, pages 28-33.
Crossref
Kirk P. Conrad & S. Ananth Karumanchi. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2689
2761
.
Thomas F. McElrath, Kee-Hak Lim, Emmanuelle Pare, Janet Rich-Edwards, Dominick Pucci, Rebecca Troisi & Samuel Parry. (2012) Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. American Journal of Obstetrics and Gynecology 207:5, pages 407.e1-407.e7.
Crossref
Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi I. Thadhani & S. Ananth Karumanchi. (2012) Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS ONE 7:10, pages e48259.
Crossref
Aida A Korish. (2012) Magnesium sulfate therapy of preeclampsia: an old tool with new mechanism of action and prospect in management and prophylaxis. Hypertension Research 35:10, pages 1005-1011.
Crossref
D. Gallot & V. Sapin. (2012) Marqueurs biologiques de la prééclampsie. EMC - Biologie Médicale 7:3, pages 1-7.
Crossref
Sarosh RanaMichele R. HackerAnna Merport ModestSaira SalahuddinKee-Hak LimStefan VerlohrenFrank H. PerschelS. Ananth Karumanchi. (2012) Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia. Hypertension 60:2, pages 451-458.
Crossref
Bálint Alasztics, Zoltán Kukor, Zita Pánczél & Sándor Valent. (2012) The pathophysiology of preeclampsia in view of the two-stage model. Orvosi Hetilap 153:30, pages 1167-1176.
Crossref
CE Kleinrouweler, MMJ Wiegerinck, C Ris‐Stalpers, PMM Bossuyt, JAM van der Post, P von Dadelszen, BWJ Mol & E Pajkrt. (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 119:7, pages 778-787.
Crossref
Henning Hagmann, Ravi Thadhani, Thomas Benzing, S Ananth Karumanchi & Holger Stepan. (2012) The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry 58:5, pages 837-845.
Crossref
Sarosh RanaCamille E. PoweSaira SalahuddinStefan VerlohrenFrank H. PerschelRichard J. LevineKee-Hak LimJulia B. WengerRavi ThadhaniS. Ananth Karumanchi. (2012) Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation 125:7, pages 911-919.
Crossref
Augustine RajakumarAna Sofia CerdeiraSarosh RanaZsuzsanna ZsengellerLia EdmundsArun JeyabalanCarl A. HubelIsaac E. StillmanSamir M. ParikhS. Ananth Karumanchi. (2012) Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia. Hypertension 59:2, pages 256-264.
Crossref
V.L. Clifton, M.J. Stark, A. Osei-Kumah & N.A. Hodyl. (2012) Review: The feto-placental unit, pregnancy pathology and impact on long term maternal health. Placenta 33, pages S37-S41.
Crossref
Yuxuan Chen & Zhenyu Zhang. (2012) Placenta related pathogenic factors for preeclampsia. Open Journal of Obstetrics and Gynecology 02:04, pages 340-345.
Crossref
Reem Mustafa, Sana Ahmed, Anu Gupta & Rocco C. Venuto. (2012) A Comprehensive Review of Hypertension in Pregnancy. Journal of Pregnancy 2012, pages 1-19.
Crossref
Marni Jacobs, Natasha Nassar, Christine L Roberts, Ruth Hadfield, Jonathan M Morris & Anthony W Ashton. (2011) Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reproductive Biology and Endocrinology 9:1.
Crossref
Wenda RammaAsif Ahmed. (2011) Is inflammation the cause of pre-eclampsia?. Biochemical Society Transactions 39:6, pages 1619-1627.
Crossref
MARIA PALM, SAMAR BASU, ANDERS LARSSON, LISA WERNROTH, HELENA ÅKERUD & OVE AXELSSON. (2011) A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstetricia et Gynecologica Scandinavica 90:11, pages 1244-1251.
Crossref
J. Espinoza & A. F. Espinoza. (2011) Pre-eclampsia: a maternal manifestation of a fetal adaptive response?. Ultrasound in Obstetrics & Gynecology 38:4, pages 367-370.
Crossref